deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT01072136

Empiric Therapy of Mucopurulent Cervicitis (MPC)

A Randomized Trial to Evaluate the Need for Empiric Therapy for Mucopurulent Cervicitis of Unknown Etiology

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions Cervicitis Vaginitis Bacterial
Interventions Azithromycin Cefixime Placebo
Updated 9 times since 2017 Last updated: Dec 4, 2014 Started: Mar 31, 2010 Primary completion: Sep 30, 2011 Completion: Dec 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute of Allergy and Infectious Diseases (NIAID)

More terminations from National Institute of Allergy and Infectious Diseases (NIAID)

Listed as NCT01072136, this PHASE3 trial focuses on Cervicitis and Vaginitis Bacterial and remains terminated or withdrawn. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 9 times since 2010, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE3

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE3

▶ Show 4 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE3

  2. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  3. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE3

    First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations